IP Library › Assignment 035806/0320
Patent Assignment
Reel/Frame 035806/0320

Assignment of Assignor's Interest

Recorded: 2015-06-02 Pages: 26
Assignor
GLAXOSMITHKLINE LLC
Executed: 2015-03-01
Assignee
GLAXO GROUP LIMITED
980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX, ENGLAND, TW8 9GS, UNITED KINGDOM
Covered Properties (51)
9-Beta-D-Arabinofuranasyl-2-Amino-6-Methoxy-9H-Purine
Patent: 5,424,295 →
Application: 08/110,487 →
Treatment of Ovarian Cancer
Patent: 5,674,872 →
Application: 08/411,056 →
Tumor Treatment with Arabinofuranosyl Purine Derivatives
Patent: 5,821,236 →
Application: 08/449,078 →
Therapeutic Methods for Using Ara-G Derivatives
Patent: 5,747,472 →
Application: 08/456,186 →
Novel Metal Complexes
Patent: 6,280,959 →
Application: 09/530,307 →
Publication: US 2001/0014454
Thrombopoietin Mimetics
Patent: 7,160,870 →
Application: 10/296,688 →
Publication: US 2004/0019190
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hy-Drazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 7,547,719 →
Application: 10/515,304 →
Publication: US 2006/0178518
Crystalline Topotecan Hydorchloride Product and Process for Making the Same
Patent: 7,754,733 →
Application: 10/578,660 →
Publication: US 2007/0117832
Thrombopoietin Mimetics
Patent: 7,335,649 →
Application: 11/558,071 →
Publication: US 2007/0179192
Thrombopoietin Mimetics
Patent: 7,332,481 →
Application: 11/620,260 →
Publication: US 2007/0129338
Thrombopoietin Mimetics
Patent: 7,473,686 →
Application: 11/650,651 →
Publication: US 2008/0214640
Thrombopoietin Mimetics
Patent: 7,439,342 →
Application: 11/650,688 →
Publication: US 2008/0090996
Thrombopoietin Mimetics
Patent: 7,452,874 →
Application: 11/650,838 →
Publication: US 2008/0090787
Thrombopoietin Mimetics
Patent: 7,674,887 →
Application: 12/141,379 →
Publication: US 2009/0176973
Thrombopoietin Mimetics
Patent: 7,790,704 →
Application: 12/141,397 →
Publication: US 2009/0155203
Thrombopoietin Mimetics
Patent: 7,648,971 →
Application: 12/141,422 →
Publication: US 2009/0176746
Benzene Sulfonamide Thiazole and Oxazole Compounds
Patent: 7,994,185 →
Application: 12/434,963 →
Publication: US 2009/0298815
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 7,795,293 →
Application: 12/472,819 →
Publication: US 2009/0291995
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,071,129 →
Application: 12/607,284 →
Publication: US 2010/0040683
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,052,993 →
Application: 12/607,291 →
Publication: US 2010/0040684
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,052,994 →
Application: 12/607,305 →
Publication: US 2010/0047346
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,062,665 →
Application: 12/607,320 →
Publication: US 2010/0047347
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,052,995 →
Application: 12/607,330 →
Publication: US 2010/0047348
Novel Compound, Corresponding Compositions, Preparation and/or Treatment Methods
Patent: 8,158,645 →
Application: 12/770,898 →
Publication: US 2010/0210677
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,088,813 →
Application: 12/873,565 →
Publication: US 2011/0081312
Benzene Sulfonamide Thiazole and Oxazole Compounds
Patent: 8,415,345 →
Application: 12/991,004 →
Publication: US 2011/0172215
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,828,430 →
Application: 13/272,367 →
Publication: US 2012/0093927
Method of Treating Thrombocytopenia
Patent: 8,476,249 →
Application: 13/318,550 →
Publication: US 2012/0052055
Methods of Administration of Thrombopoietin Agonist Compounds
Patent: 8,609,693 →
Application: 13/321,577 →
Publication: US 2012/0064036
A Non-Peptide Thrombopoietin Receptor Agonist in the Treatment of Cancer and Pre-Cancerous Syndromes
Patent: 8,637,563 →
Application: 13/487,512 →
Publication: US 2012/0295918
Pharmaceutical Combination of MEK Inhibitor and B-RAF Inhibitors
Patent: 8,703,781 →
Application: 13/499,779 →
Publication: US 2012/0196879
Combination
Application: 13/501,387 →
Publication: US 2012/0202822
Thrombopoietin Mimetics
Application: 13/593,739 →
Publication: US 2013/0078213
Combination of Lapatinib and Trametinib
Patent: 9,180,129 →
Application: 13/699,077 →
Publication: US 2013/0109705
Benzene Sulfonamide Thiazole and Oxazole Compounds
Patent: 8,642,759 →
Application: 13/755,466 →
Publication: US 2013/0144055
Combination of BRAF and VEGF Inhibitors
Application: 13/820,834 →
Publication: US 2013/0172378
3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
Patent: 8,846,024 →
Application: 14/050,976 →
Publication: US 2014/0037580
Benzene Sulfonamide Thiazole and Oxazole Compounds
Patent: 9,233,956 →
Application: 14/088,598 →
Publication: US 2014/0080851
Methods for Treating Degenerative Diseases/Injuries
Application: 14/100,560 →
Publication: US 2014/0100258
Method of Treating Thrombocytopenia
Application: 14/150,112 →
Publication: US 2014/0142155
Pharmaceutical Combination of Mek Inhibitor and B-Raf Inhibitors
Patent: 8,952,018 →
Application: 14/197,421 →
Publication: US 2014/0187566
Combination
Application: 14/270,774 →
Publication: US 2015/0094321
Cancer Treatment Method
Application: 14/291,667 →
Publication: US 2014/0275107
Methods for Treating Degenerative Diseases/Injuries
Application: 14/293,209 →
Publication: US 2014/0275193
Combination
Application: 14/309,262 →
Publication: US 2014/0303195
Combination
Application: 14/317,775 →
Publication: US 2014/0309243
Method of Adjuvant Cancer Treatment
Application: 14/422,182 →
Publication: US 2015/0216868
3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
Application: 14/450,569 →
Publication: US 2014/0341991
3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
Application: 14/478,134 →
Publication: US 2015/0079030
Thrombopoietin Mimetics
Application: 14/567,277 →
Publication: US 2015/0093356
Pharmaceutical Combination of Mek Inhibitor and B-Raf Inhibitors
Application: 14/578,804 →
Publication: US 2015/0111904
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 22, 2009
From: DELL'ORCO, PHILIP C.; DIEDERICH, ANN MARIE; SU, QIAOGONG; WOOD, JEFFERY LEE
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 022853/0079 →
Assignment of Assignor's Interest Aug 13, 2009
From: GLAXO GROUP LIMITED
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 023096/0656 →
Change of Name Dec 15, 2009
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023649/0370 →
Change of Name Jan 6, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023731/0761 →
Change of Name Jan 6, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023731/0744 →
Change of Name Jan 6, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023731/0766 →
Change of Name Jan 15, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023794/0158 →
Change of Name Jan 15, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023794/0337 →
Change of Name Jan 29, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023869/0366 →
Assignment of Assignor's Interest Oct 26, 2010
From: ADJABENG, GEORGE; HORNBERGER, KEITH
To: GLAXOSMITHKLINE LLC
Reel/Frame 025196/0519 →
Assignment of Assignor's Interest Apr 21, 2014
From: RHEAULT, TARA RENAE
To: GLAXOSMITHKLINE LLC
Reel/Frame 032717/0765 →
Change of Name Oct 16, 2014
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 034009/0663 →
Assignment of Assignor's Interest Jun 2, 2015
From: GLAXO GROUP LIMITED
To: NOVARTIS PHARMA AG
Reel/Frame 035806/0563 →
Assignment of Assignor's Interest Jun 3, 2015
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 035812/0424 →
Assignment of Assignor's Interest Feb 3, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 073667/0658 →